Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access

American Journal of Kidney Diseases

Volumn 37, Issue 5, 2001, Pages 970-980

  Weiss, Miriam F ^a   Scivittaro, Vincenzo ^a   Anderson, James M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4 hydroxy 2,3 nonenol (HNE); Anastomotic hyperplasia; Arteriovenous (AV) fistula; Endothelin 1 (ET 1); Expanded polytetrafluoroethylene (ePTFE) graft; Hemodialysis (HD); Intimal hyperplasia; N (carboxymethyl)lysine (CML); Neointima; Platelet derived growth factor (PDGF); Pseudointima; Transforming growth factor (TGF )

Indexed keywords

4 HYDROXYNONENAL; 6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ENDOTHELIN 1; PLATELET DERIVED GROWTH FACTOR; POLITEF; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HEALING; HEMODIALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; OXIDATIVE STRESS; VASCULAR ACCESS;

EID: 0035012975     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(05)80013-7     Document Type: Article

References (50)

1. Hakim R. Himmelfarb J. Hemodialysis access failure: A call to action Kidney Int 54 1998 1029 1040
2. US Renal Data System: USRDS 1999 Annual Data Report 1999
3. Golden M. Au Y. Kenagy R. Clowes A. Growth factor gene expression by intimal cells in healing polytetrafluoroethylene grafts J Vasc Surg 11 1990 580 585
4. Swedberg S. Brown G. Sigley R. Wight T. Gordon D. Nicholls S. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients: Clinical, immunocytochemical, light and electron microscopic assessment Circulation 80 1989 1726 1736
5. Hehrlein C. How do A-V fistulae lose function? The roles of haemodynamics, vascular remodelling, and intimal hyperplasia Nephrol Dial Transplant 10 1995 1287 1290
6. Gibbons G. Dzau V/ The emerging concept of vascular remodeling N Engl J Med 330 1994 1431 1438
7. Roy-Chaudhury P. Whiting J. Miller M. Reaves A. Denman D. Munda R. First M. Heffelfinger S. Neointimal hyperplasia and hemodialysis dysfunction: A pathogenetic role for cytokines, matrix proteins, and specific cell types Henry M. Vascular Access for Hemodialysis—VI 1999 Precept Press Chicago, IL 55 60
8. Roselaar S. Nazhat N. Winyard P. Jones R. Cunningham J. Blake D. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy Kidney Int 48 1995 199 206
9. Witko-Sarsat V. Friedlander M. Capeillere-Blandin C. Nguyen-Khoa T. Nguyen A. Zingraff J. Jungers P. Descamps-Latscha B. Advanced oxidative protein products as a novel marker of oxidative stress in uremia Kidney Int 49 1996 1304 1313
10. Loughrey C. Young I. Lightbody J. McMaster D. McNamee P. Trimbel E. Oxidative stress in hemodialysis Q J Med 87 1994 679 683
11. Descamps-Latscha B. Goldfarb B. Nguyen A. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: Arandomized prospective study Nephron 59 1991 279 285
12. Himmelfarb J. Ault K. Holbrook D. Leeber D. Hakim R. Intradialytic granulocyte reactive oxygen species production: A prospective crossover trial J Am Soc Nephrol 4 1993 178 186
13. Zima T. Haragsim L. Stipek S. Bartova V. Nemecek K. Lipid peroxidation on dialysis membranes Biochem Mol Biol Int 29 1993 531 537
14. Toborek M. Wasik T. Drodz M. Klin M. Magner-Wrobel K. Kopiecna-Grzebieniak E. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure Metabolism 41 1992 1229 1232
15. Miyata T. Ueda Y. Yamada Y. Izuhara Y. Wada T. Jadoul M. Saito A. Kurokawa K. van Ypersele de Strihou C. Accumulation of carbonyls accelerates the formation of pentosidine, and advanced glycation end product: Carbonyl stress in uremia J Am Soc Nephrol 9 1998 2349 2356
16. Miyata T. van Ypersele de Strihou C. Kurokawa K. Baynes I. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress― in longterm uremic complications Kidney Int 55 1999 389 399
17. Monnier V.M. Sell D.R. Miyata S. Nagaraj R.H. Odetti P. Lapolla A. Advanced Maillard reaction products as markers for tissue damage in diabetes and uraemia: Relevance to diabetic nephropathy Acta Diabetol 29 1992 130 135
18. Friedlander M. Wu Y. Schulak J. Monnier V. Hricik D. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease Am J Kidney Dis 25 1995 445 451
19. Miyata T. Ueda Y. Shinzato T. Iida Y. Tanaka S. Kurokawa K. van Ypersele de Strihou C. Maeda K. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end stage renal failure: Renal implications in the pathophysiology of pentosidine J Am Soc Nephrol 7 1996 1198 1206
20. Saxena A. Saxena P. Wu X. Obrenovich M. Weiss M. Monnier V. Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: Relevance to diseases ofglycoxidative stress Biochem Biophys Res Common 260 1999 332 339
21. Barcellos-Hoff M. Dix T. Redox mediated activation of latent transforming growth factor-beta I Mol Endocrinol 10 1996 1077 1083
22. Leonarduzzi G. Scavazza A. Biasi F. Chiarpotto E. Camandola S. Vogl S. Dargel R. Poli G. The lipid peroxidation end product 4-hydroxy-2,3-nonenol up-regulates transforming growth factor β1 expression in the macrophage lineage: A link between oxidative injury and fibrosclerosis FASEB J 11 1997 851 857
23. Aviram M. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation Thromb Haemost 74 1995 560 564
24. Porter K. Olojugba D. Masood I. Pemberton M. Bell P. London N. Endothelin-B receptors mediate intirnal hyperplasia in an organ culture of human saphenous vein J Vasc Surg 28 1998 695 701
25. Merrilees M. Beaumont B. Scott L. Hermanutz V. Fennessy P. Effect of TGF-β1 antisense S-oligonucleotide on synthesis and accumulation of matrix proteoglycans in balloon catheter-injured neointima ofrabbit carotid arteries J Vasc Res 37 2000 50 60
26. Kaiura T. Itoh H. Kubaska S. McCaffrey T. Liu B. Kent K. The effect of growth factors, cytokines and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells J Vasc Surg 31 2000 577 584
27. Ombrellaro M. Stevens S. Schaeffer D. Freeman M. Sciarrotta J. Carroll R. Goldman M. The role of plateletderived growth factor in intraluminal scented graft healing J Am Coll Surg 184 1997 49 57
28. (abstr) Hricik D. Herman W. Weiss M. Simonson M. Renal deposition of the advanced glycation end-product Ne(carboxymethyl)lysine after kidney or kidney-pancreas transplantation J Am Soc Nephrol 10 1999 75A
29. Dominguez I. Tang N. Xu W. Evan A. Siakotos A. Agarwal R. Walsh J. Deeg M. Pratt J. March K. Monnier V. Weiss M. Baynes J. Peterson R. Studies of renal injury III: Lipid-induced nephropathy in type 11 diabetes Kidney Int 57 2000 92 104
30. Schwedler S, Verbeke P, Bakala H, Weiss M, Vilar J,Depreux P, Fourmaintraux E, Striker L, Striker G: N -Phenylacylthiazolium bromide (PTB) decreases renal AGES other than Nε(carboxymethyl)lysine and pentosidine and increases urinary AGE excretion, without ameliorating diabetic nephropathy in C57BL/6 mice. Diabetes (in press)
31. Sayre L. Perry G. Smith M. In situ methods for detection and localization of markers of oxidative stress: Application to the study of neurodegenerative disorders Methods Enzymol 309 1999 133 152
32. Sukhatme V.P. Vascular access stenosis: Prospects for prevention and therapy Kidney Int 49 1996 1161 1174
33. Simonson M. Endothelins: Multifunctional renal peptides Physiol Rev 73 1993 375 411
34. Wilkie M. Khandan-Nia N. Ghatei A. Bloom S. Raftery M. Cunningham J. Does the arteriovenous fistula in chronic hemodialysis patients stimulate endothelin-I release? Nephrol Dial Transplant 7 1992 1019 1021
35. Masood I. Porter K. London N. Endothelin-I is a mediator of intimal hyperplasia in organ culture of human saphenous vein Br J Surg 84 1997 499 503
36. Miyauchi T. Masaki T. Pathophysiology of endothelin in the cardiovascular system Annu Rev Physiol 61 1999 391 415
37. Anderson I. Abbuhl M. Hering T. Johnston K. Immunohistochemical identification of components in the healing response of human vascular grafts ASAIO J 8 1985 79 85
38. Faries P. Marin M. Veith F. Ramirez J. Suggs W. Parsons R. Sanchez L. Lyon R. Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimentalmodel J Vase Surg 24 1996 463 471
39. Sottiurai V. Yao J. Flinn W. Batson R. Intimal hyperplasia and neointima: An ultrastructural analysis of thromhosed grafts in humans Surgery 93 1983 809 817
40. Rekhter M. Nicholls S. Ferguson M. Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis Arterioscler Thromb 13 1993 609 617
41. Anderson J. Inflammatory reaction: The nemesis of implants Zilla P. Greisler H.P. Tissue Engineering of Vascular Prosthetic Grafts 1999 Landes Austin, TX 197 206
42. Border W. Ruoslati E. Transforming growth factor-β in disease: The dark side of tissue repair J Clin Invest 90 1992 1 7
43. Nabel E. Shum L. Pompili V. Yang Z. San H. Shu H. Liptay S. Gold L. Gordon D. Derynck R. Nabel G. Direct transfer of transforming growth factor-β gene into arteries stimulates fibrocellular hyperplasia Proc Natl Acad Sci U S A 90 1993 10759 10763
44. Wolf Y. Rasmussen L. Ruoslahati E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model J Clin Invest 93 1996 1172 1178
45. Anderson M. Hazen S. Hsu F. Heinecke J. Human neutrophils employ the myeloperoxidase-hydrogen peroxidechloride system to convert hydroxy-amino acids into glycoaldehyde, 2-hydroxypropanal and acrolein: A mechanism for the generation of highly reactive a-hydroxy and α,βunsaturated aldehydes by phagocytes at sites of inflammation J Clin Invest 99 1997 397 403
46. Hazen S. Hsu F. d'Avignon A. Heinecke J. Human neutrophils employ myeloperoxidase to convert alphaamino acids to a battery of reactive aldehydes: A pathway for aldehyde generation at sitesof inflammation Biochemistry 37 1998 6864 6873
47. Yan S. Schmidt A. Anderson G. Zhang J. Brett J. Zou Y. Pinsky D. Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins J Biol Chem 269 1994 9889 9897
48. Vlassara H. Fuh H. Makita Z. Krungkrai S. Cerami A. Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: A model for diabetic and aging complications Proc Natl Acad Sci U S A 89 1992 12043 12047
49. Wautier J.L. Wautier M.P. Schmidt A.M. Anderson G.M. Hori O. Zoukourian C. Capron L. Chappey O. Yan S.D. Brett J. Guillausseau P.J. Stern D. Advanced glycation end products (AGES) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidantstress in the vasculature: A link between surface associated AGES and diabetic complications Proc Natl Acad Sci U S A 91 1994 7742 7746
50. Huynh T. Davies M. Trovato M. Barber L. Safi H. Hagen P.-O. Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts J Surg Res 84 1999 223 232